Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ataibeckley Inc (ATAI)

Ataibeckley Inc (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,347,439
  • Shares Outstanding, K 363,191
  • Annual Sales, $ 310 K
  • Annual Income, $ -149,270 K
  • EBIT $ -104 M
  • EBITDA $ -104 M
  • 60-Month Beta 1.61
  • Price/Sales 226.63
  • Price/Cash Flow N/A
  • Price/Book 5.59

Options Overview Details

View History
  • Implied Volatility 99.36% (+4.11%)
  • Historical Volatility 52.14%
  • IV Percentile 14%
  • IV Rank 8.41%
  • IV High 392.08% on 04/08/25
  • IV Low 72.46% on 12/18/25
  • Expected Move (DTE 35) 0.76 (20.78%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 2,370
  • Volume Avg (30-Day) 1,926
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 90,880
  • Open Int (30-Day) 84,831
  • Expected Range 2.88 to 4.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.12
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.16
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.60 +1.11%
on 01/13/26
4.72 -22.88%
on 12/23/25
-0.59 (-13.95%)
since 12/16/25
3-Month
3.60 +1.11%
on 01/13/26
6.75 -46.07%
on 10/20/25
-1.84 (-33.58%)
since 10/16/25
52-Week
1.15 +216.52%
on 04/09/25
6.75 -46.07%
on 10/20/25
+2.25 (+161.87%)
since 01/16/25

Most Recent Stories

More News
The 1 Riskiest Investment That Paid Off in 2025

Wall Street still sees triple-digit upside in this high-risk biotech bet.

ATAI : 3.64 (-1.89%)
$SPX : 6,940.01 (-0.06%)
MarketBeat’s Top 5 Rated Small-Cap Stocks

Small-cap stocks are regaining momentum as rate cuts and the end of quantitative tightening drive a renewed risk-on environment.

ATAI : 3.64 (-1.89%)
TRVI : 10.48 (-2.60%)
CRMD : 6.78 (-3.28%)
TREE : 68.01 (+1.25%)
MNMD : 15.02 (+1.01%)
IWM : 265.76 (+0.09%)
Enhanced Fortifies Executive Leadership Team & Board of Directors

– Co-Founder Maximilian Martin Appointed CEO –

ATAI : 3.64 (-1.89%)
North Carolina Wants to ‘Lead the Nation’ in Psychedelics. Here’s 1 ‘Strong Buy’ Stock to Buy Now.

As policy meets potential in North Carolina, Atai Life Sciences could be a solid portfolio addition now.

ATAI : 3.64 (-1.89%)
JNJ : 218.66 (-0.41%)
ATAI Life Sciences to Acquire Beckley Psytech

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. ATAI Life...

ATAI : 3.64 (-1.89%)
Brera Holdings (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI

Brera Holdings (NASDAQ: BREA), which is rebranding as Solmate and pivoting to a Solana-based digital asset treasury and crypto infrastructure, surged after Cathie Wood’s ARK Invest purchased 6,500,001...

ROKU : 103.66 (-1.25%)
BREA : 25.20 (+1.94%)
AVAV : 392.86 (+3.77%)
ATAI : 3.64 (-1.89%)
BIDU : 149.53 (+0.09%)
ARCT : 7.29 (-4.20%)
PONY : 16.30 (+2.71%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

CMPS : 7.35 (+0.55%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.64 (-1.89%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END

CMPS : 7.35 (+0.55%)
CYBN.NE : 11.5800 (+4.23%)
ATAI : 3.64 (-1.89%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 8.68 (-0.23%)
MNMD : 15.02 (+1.01%)
CYBN : 8.28 (+1.22%)
2 ‘Strong Buy’ Psychedelic Stocks to Scoop Up ASAP

Two psychedelic-focused stocks stand to benefit after the FDA designated psychedelics as a top review priority.

ATAI : 3.64 (-1.89%)
MNMD : 15.02 (+1.01%)
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

CMPS : 7.35 (+0.55%)
ATAI : 3.64 (-1.89%)
MNMD : 15.02 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

AtaiBeckley Inc. is a clinical-stage biopharmaceutical company developing mental health treatments. The company's pipeline of novel therapies includes BPL-003 for treatment-resistant depression, VLS-01 for TRD and EMP-01 for social anxiety disorder. AtaiBeckley Inc., formerly known as Atai Beckley...

See More

Key Turning Points

3rd Resistance Point 3.85
2nd Resistance Point 3.79
1st Resistance Point 3.72
Last Price 3.64
1st Support Level 3.59
2nd Support Level 3.53
3rd Support Level 3.46

See More

52-Week High 6.75
Fibonacci 61.8% 4.61
Fibonacci 50% 3.95
Last Price 3.64
Fibonacci 38.2% 3.29
52-Week Low 1.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar